Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations

Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations

Marina Scolnik1, Gurkirpal Singh21Sección Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; 2Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford,...

Full description

Bibliographic Details
Main Authors: Scolnik M, Singh G
Format: Article
Language:English
Published: Dove Medical Press 2011-08-01
Series:Open Access Rheumatology : Research and Reviews
Online Access:http://www.dovepress.com/combination-therapy-versus-celecoxib-a-single-selective-cox-2-agent-to-a8016

Internet

http://www.dovepress.com/combination-therapy-versus-celecoxib-a-single-selective-cox-2-agent-to-a8016

Similar Items